Names that match “NEW LEAF VENTURES III, L.P”
5,190 documents found
the trust is irrevocable and Mr. Garcia IJ is not a beneficiary. Mr. Garcia III is the sole
document investment trustees over Ernest Irrevocable 2004 Trust IIT House Oversight Committee — Epstein Estate Records (Nov 2025)
the trust is irrevocable and Mr. Garcia IJ is not a beneficiary. Mr. Garcia III is the sole
and four additional ALS ambulances typically Type III models allowing for
document Response Vehicles House Oversight Committee — Epstein Estate Records (Nov 2025)
and four additional ALS ambulances typically Type III models allowing for
a Class III medical device approved by FDA in 1993. The
document generation product was the FC1 Female Condom House Oversight Committee — Epstein Estate Records (Nov 2025)
a Class III medical device approved by FDA in 1993. The
and (iii) markets continue to be sceptical of a 2016 MMAR
document allocations are historically elevated House Oversight Committee — Epstein Estate Records (Nov 2025)
and (iii) markets continue to be sceptical of a 2016 MMAR
Plaintiffs have failed to state a RICO claim
document IMAGES-004-HOUSE_OVERSIGHT_017893.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
…ly plead the pro-
vision of material support under this sec-
tion, a plaintiff would have to allege that
the defendant knew about the terrorists’
illegal activities, the defendant desired to
help those activities succeed, and the de-
fendant engaged in some act of helping
those a...
On Sun, Mar 17, 2019 at 11:48 AM Larry Summers iii. wrote
document IMAGES-012-HOUSE_OVERSIGHT_033449.txt Mar 17, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)
On Sun, Mar 17, 2019 at 11:48 AM Larry Summers iii. wrote:
Sent from my iPad
Please direct all scheduling inquiries to my office at:
Follow me on twitter @lhsummers
www.larrysummers.com
On Mar 17, 2019, at 9:49 AM, J <[email protected]> wrote:
coming from you -- not mutu...
and (iii) a “Marijuana Termination” SAR if the
document state law or implicates any Cole Memo priority House Oversight Committee — Epstein Estate Records (Nov 2025)
and (iii) a “Marijuana Termination” SAR if the
(ii) development (5) follows two years thereafter and (iii) development (6) occurs by 2027 and
document in 2023 House Oversight Committee — Epstein Estate Records (Nov 2025)
(ii) development (5) follows two years thereafter and (iii) development (6) occurs by 2027 and
(ii) the addition of states and (iii) same-store growth in existing states
document grades House Oversight Committee — Epstein Estate Records (Nov 2025)
(ii) the addition of states and (iii) same-store growth in existing states.
(iii) offer Partners the opportunity to exchange their Common LP Units
document the Initial Listing to the Partners House Oversight Committee — Epstein Estate Records (Nov 2025)
(iii) offer Partners the opportunity to exchange their Common LP Units
364 shares of k12 common stock at $1.60 per share and (iii) warrants to
document warrants to purchase 53 House Oversight Committee — Epstein Estate Records (Nov 2025)
364 shares of k12 common stock at $1.60 per share and (iii) warrants to
two Phase III trials in Lennox-Gastaut syndrome (LGS)
document Phase III trials in Dravet House Oversight Committee — Epstein Estate Records (Nov 2025)
two Phase III trials in Lennox-Gastaut syndrome (LGS)
and a Phase II/III trial in infantile spasms. The first
document III trial in tuberous sclerosis complex House Oversight Committee — Epstein Estate Records (Nov 2025)
and a Phase II/III trial in infantile spasms. The first
varies between different banks and (iii)
document likely impact from a more hawkish ECB House Oversight Committee — Epstein Estate Records (Nov 2025)
varies between different banks and (iii)
and is positioned well for continued success in NLV-III
document dynamic sector House Oversight Committee — Epstein Estate Records (Nov 2025)
and is positioned well for continued success in NLV-III.
